Skip to main content
Federal Lobbying Data · Senate LDA Filings · Updated Quarterly
LobbySpend

Novo Nordisk

Pharmaceutical & Health Products · Lobbying Client

C
Influence Score
50/100
Moderate Influence
$12.2M
Total Lobby Spend
5
Policy Issues
8
Lobbyists
1
Revolving Door

Novo Nordisk reported $12.2 million in federal lobbying expenditures (2020-2024) as disclosed in Senate LDA filings. The organization's lobbying activity spans 5 policy areas, with primary focus on Health Issues, Pharmacy, Medical/Disease Research. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995. All lobbying disclosure data sourced from Senate lobbying disclosure filings filed under the Lobbying Disclosure Act.

Annual Lobbying Spend

Policy Issues

Government Entities Contacted

Dept of Education
Small Business Administration
U.S. Senate
Dept of Agriculture
U.S. House of Representatives
Dept of the Treasury
Office of the U.S. Trade Representative
Food & Drug Administration

Recent Filings

PeriodRegistrantIssuesLobbyistsAmount
2024 Oct-DecAkin Gump Strauss Hauer & Feld
PHAHCRGOV+1
2$680K
2024 Jul-SepCapitol Counsel
TAXMED
2$536K
2024 Apr-JunSteptoe & Johnson
PHAHCRTAX+2
3$652K
2024 Jan-MarTarplin, Downs & Young
GOVTAXHCR+2
2$671K
2023 Oct-DecCovington & Burling
HCRPHATAX+2
2$831K
2023 Jul-SepStewart & Stewart
HCRGOVTAX+2
3$645K
2023 Apr-JunPrime Policy Group
MEDHCRTAX
1$618K
2023 Jan-MarCornerstone Government Affairs
GOVTAXPHA+2
4$795K

Novo Nordisk Lobbying FAQ

Novo Nordisk has spent $12.2M on federal lobbying across 5 policy areas. This includes spending on registered lobbyists and direct government contacts.

Novo Nordisk lobbies on 5 policy issues, including Health Issues, Pharmacy, Medical/Disease Research, Taxation. These disclosures are filed quarterly with the Senate Office of Public Records.

Novo Nordisk has an Influence Score of 50/100 (Grade C). This proprietary score is based on total lobby spend (40%), policy issue breadth (30%), and revolving door connections (30%).

Novo Nordisk employs 8 registered lobbyists, of whom 1 have revolving door connections, meaning they previously held government positions before becoming lobbyists.

Novo Nordisk has contacted 8 government entities as part of their lobbying activities, including Dept of Education, Small Business Administration, U.S. Senate.

Sources: Senate Office of Public Records (LDA), OpenSecrets.org
Last updated:

Lobbying data is sourced from quarterly Lobbying Disclosure Act (LDA) filings with the Senate Office of Public Records. Influence Scores combine total spend (40%), issue breadth (30%), and revolving door connections (30%). Filings may be amended after initial submission.